180 related articles for article (PubMed ID: 16545537)
1. [Toxic epidermal necrolysis. Epidemiologic, clinic and therapeutic aspects at Cotonou University and National Teaching Hospital].
Aguèmon AR; Houngbé F; Yaméogo TM; Tchaou B; Madougou S; Lokossou T; Hounkpè PC
Ann Fr Anesth Reanim; 2006 May; 25(5):505-9. PubMed ID: 16545537
[TBL] [Abstract][Full Text] [Related]
2. A 12-year retrospective study of non-burn skin loss (burn-like syndromes) at a tertiary burns unit in a developing country.
Ugburo AO; Temiye EO; Ilombu CA
Burns; 2008 Aug; 34(5):637-43. PubMed ID: 18226456
[TBL] [Abstract][Full Text] [Related]
3. Uncovering histologic criteria with prognostic significance in toxic epidermal necrolysis.
Quinn AM; Brown K; Bonish BK; Curry J; Gordon KB; Sinacore J; Gamelli R; Nickoloff BJ
Arch Dermatol; 2005 Jun; 141(6):683-7. PubMed ID: 15967913
[TBL] [Abstract][Full Text] [Related]
4. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
[TBL] [Abstract][Full Text] [Related]
5. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome).
Guillaume JC; Roujeau JC; Revuz J; Penso D; Touraine R
Arch Dermatol; 1987 Sep; 123(9):1166-70. PubMed ID: 3632001
[TBL] [Abstract][Full Text] [Related]
6. Intensive care unit admissions in the Jos University Teaching Hospital.
Isamade ES; Yiltok SJ; Uba AF; Isamade EI; Daru PH
Niger J Clin Pract; 2007 Jun; 10(2):156-61. PubMed ID: 17902510
[TBL] [Abstract][Full Text] [Related]
7. [Lyell syndrome in Senegal: responsibility of thiacetazone].
Mame Thierno D; On S; Thierno Ndiaye S; Ndiaye B
Ann Dermatol Venereol; 2001 Dec; 128(12):1305-7. PubMed ID: 11908132
[TBL] [Abstract][Full Text] [Related]
8. Burn center care for patients with toxic epidermal necrolysis.
Kelemen JJ; Cioffi WG; McManus WF; Mason AD; Pruitt BA
J Am Coll Surg; 1995 Mar; 180(3):273-8. PubMed ID: 7874336
[TBL] [Abstract][Full Text] [Related]
9. Prospective, noncomparative open study from Kuwait of the role of intravenous immunoglobulin in the treatment of toxic epidermal necrolysis.
Al-Mutairi N; Arun J; Osama NE; Amr Z; Mazen AS; Ibtesam el-A; Nazeha el-B
Int J Dermatol; 2004 Nov; 43(11):847-51. PubMed ID: 15533072
[TBL] [Abstract][Full Text] [Related]
10. Toxic epidermal necrolysis: analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients.
Kim KJ; Lee DP; Suh HS; Lee MW; Choi JH; Moon KC; Koh JK
Acta Derm Venereol; 2005; 85(6):497-502. PubMed ID: 16396796
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
12. Toxic epidermal necrolysis: 15 years' experience in a Dutch burns centre.
Gerdts B; Vloemans AF; Kreis RW
J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):781-8. PubMed ID: 17567308
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy.
Guibal F; Bastuji-Garin S; Chosidow O; Saiag P; Revuz J; Roujeau JC
Arch Dermatol; 1995 Jun; 131(6):669-72. PubMed ID: 7778917
[TBL] [Abstract][Full Text] [Related]
14. [Toxic epidermal necrolysis and Stevens-Johnson syndrome].
Roujeau JC
Rev Prat; 2007 Jun; 57(11):1165-70. PubMed ID: 17691257
[TBL] [Abstract][Full Text] [Related]
15. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
16. [Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo].
Pitche P; Mouzou T; Padonou C; Tchangai-Walla K
Med Trop (Mars); 2005 Sep; 65(4):359-62. PubMed ID: 16548490
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Gueudry J; Roujeau JC; Binaghi M; Soubrane G; Muraine M
Arch Dermatol; 2009 Feb; 145(2):157-62. PubMed ID: 19221260
[TBL] [Abstract][Full Text] [Related]
18. [Drug eruptions in children in Cotonou, Benin].
Adegbidi H; Atadokpede F; Sagbo G; Koudoukpo C; D'Almeida M; Teclessou J; N'Dah P; Djoonyam A Eroume AT; Yedomon HG; Do Ango-Padonou F
Mali Med; 2012; 27(1):42-6. PubMed ID: 22947321
[TBL] [Abstract][Full Text] [Related]
19. Mortality risk and length of stay associated with self-inflicted burn injury: evidence from a national sample of 30,382 adult patients.
Thombs BD; Bresnick MG
Crit Care Med; 2008 Jan; 36(1):118-25. PubMed ID: 18090371
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of hospital-treated Salmonella infection; data from a national cohort over a ten-year period.
Gil Prieto R; Alejandre CG; Meca AA; Barrera VH; de Miguel AG
J Infect; 2009 Mar; 58(3):175-81. PubMed ID: 19195712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
